Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04526275
Other study ID # CI-B002
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date September 25, 2020
Est. completion date April 28, 2021

Study information

Verified date November 2020
Source Cearna, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Subjects will have a mechanically induced bruise photographed over a period of 11 days to record the healing process. Assessors will rate the bruises to develop a bruising scale.


Description:

Observational study. Healthy normal volunteers will come into the clinic and have a bruise induced. The bruised area will be photographed each day through Day 11. Images will be provided to the Validator Team to rate on a 0-5 scale of severity. The actual numbers of volunteers will be adjusted to ensure there are at least 15 images for each Grade. The clinical site will be provided photography equipment, and study staff will be trained on photography technique to standardize the image quality and resolution across the study. The Validator Team will review the images and categorize them in to Grades 0-5.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 27
Est. completion date April 28, 2021
Est. primary completion date March 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Fitzpatrick skin type 1-3 - BMI 25 kg/m2 - Self described bruisers - Intact skin in the target area, free of markings, blemishes and hair Exclusion Criteria: - Use of recreational drugs, steroids, pain medications, other homeopathic remedies, anticoagulant therapies, antiplatelet therapy - Known history of dermal sensitivity, serious illness, hematological abnormality, impaired wound healing - Inability to forego application of topical products in the target area - Hair removal by laser, wax or chemicals within one week prior to Day 1 - Avoid tanning beds - Active wound or infection in the target area - History of keloids or hypertrophic scarring - History of collagen or vascular disease - History of organ transplant

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Artemis Clinical Research San Diego California

Sponsors (1)

Lead Sponsor Collaborator
Cearna, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bruise Healing over time Record bruise images over 11 days 11 days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04533269 - A Study of Topical Arnica & Ledum on Bruise Reduction in HNV N/A